Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets | |||||||||
Money funds | --3.56B | 52.25%2.64B | ---- | 25.65%1.85B | 37.89%1.73B | --1.47B | 48.85%1.26B | 10.89%844.14M | --761.24M |
Transactional financial assets | ---- | --5.21M | ---- | --11.16M | ---- | ---- | ---- | --800K | ---- |
Notes receivable and accounts receivable | --969.69M | 97.34%1.01B | ---- | 11.78%770.61M | -39.17%512.92M | --689.39M | 36.53%843.15M | 136.95%617.54M | --260.62M |
-Notes receivable | --86.77K | 21.33%485.32K | ---- | --7.73M | -95.24%400K | ---- | -14.99%8.41M | 705.84%9.89M | --1.23M |
-Accounts receivable | --969.61M | 97.40%1.01B | ---- | 10.66%762.88M | -38.60%512.52M | --689.39M | 37.37%834.74M | 134.26%607.65M | --259.39M |
Other receivables (including interest and dividends) | --37.34M | 100.69%60.66M | ---- | -9.63%30.79M | -51.08%30.23M | --34.08M | 39.29%61.78M | 44.73%44.35M | --30.64M |
-Other receivable | ---- | ---- | ---- | -9.63%30.79M | -51.08%30.23M | --34.08M | 39.29%61.78M | 44.73%44.35M | --30.64M |
Advance payment | --23.3M | 40.31%16.81M | ---- | -75.51%10.46M | -10.41%11.98M | --42.7M | -44.82%13.37M | 172.33%24.23M | --8.9M |
Inventories | --685.67M | -6.27%747.97M | ---- | -27.88%617.97M | -11.46%798.01M | --856.85M | 96.96%901.34M | 37.42%457.63M | --333M |
Receivable financing | ---- | ---- | ---- | ---- | -62.25%12.43M | --19.43M | 2,451.75%32.93M | 4,508.57%1.29M | --28K |
Non-current assets due within one year | --12.15M | -96.59%817.23K | ---- | -11.36%24.35M | -64.29%23.97M | --27.47M | 109.03%67.14M | 3.02%32.12M | --31.18M |
Other current assets | --140.15M | -55.39%150.14M | ---- | 35.52%359.78M | 41.02%336.52M | --265.49M | 583.14%238.63M | -70.09%34.93M | --116.77M |
Total current assets | --5.43B | 33.91%4.63B | ---- | 7.83%3.67B | 1.28%3.46B | --3.4B | 66.01%3.41B | 33.37%2.06B | --1.54B |
Non Current assets | |||||||||
Long-term equity investment | --9.67M | -4.57%9.7M | ---- | -3.09%9.8M | 2.90%10.17M | --10.11M | 1.69%9.88M | -3.05%9.72M | --10.02M |
Long term receivable account | ---- | ---- | ---- | -82.21%699.21K | -72.63%4.35M | --3.93M | -69.15%15.89M | -39.64%51.51M | --85.35M |
Fixed assets | ---- | ---- | ---- | 102.93%54.83M | 101.76%54.56M | --27.02M | 202.97%27.04M | 46.22%8.93M | --6.1M |
Constru in process | ---- | ---- | ---- | ---- | --0 | --11.97M | ---- | ---- | ---- |
Intangible assets | --9.84M | -9.96%9.6M | ---- | 581.48%9.83M | 576.97%10.66M | --1.44M | 644.01%1.57M | -71.73%211.6K | --748.38K |
Long deferred expense | --31.39M | 20.58%32.53M | ---- | 22.72%29.15M | -1.13%26.98M | --23.75M | 8.09%27.28M | 384.87%25.24M | --5.21M |
Deferred tax assets | --51.3M | 7.94%43.11M | ---- | -31.70%34.47M | -5.85%39.93M | --50.47M | 13.06%42.42M | 31.97%37.52M | --28.43M |
Usufruct assets | --79.3M | 98.25%80.61M | ---- | 29.81%76.38M | 118.29%40.66M | --58.84M | -39.69%18.63M | --30.88M | ---- |
Other non current assets | --457.6M | 134.17%314.49M | ---- | 170.16%231.45M | 64.18%134.3M | --85.67M | 103.68%81.8M | 7.23%40.16M | --37.45M |
Total non current assets | --695.16M | 70.09%547.01M | ---- | 63.47%446.6M | 43.24%321.6M | --273.2M | 9.97%224.51M | 17.81%204.16M | --173.31M |
Total assets | --6.13B | 36.99%5.18B | --4.5B | 11.96%4.12B | 3.87%3.78B | --3.68B | 60.95%3.64B | 31.80%2.26B | --1.72B |
Liabilities | |||||||||
Current liabilities | |||||||||
Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%500K | 0.00%500K | --500K |
Transactional financial liabilities | --16.13M | ---- | ---- | ---- | -88.94%2.08M | --19.49M | --18.78M | ---- | ---- |
Notes payable and accounts payable | --1.85B | 48.63%2.12B | ---- | -20.39%1.37B | -30.92%1.43B | --1.72B | 118.39%2.07B | 32.43%945.75M | --714.13M |
-Notes payable | --1.43B | 30.54%1.18B | ---- | -26.94%728.16M | -36.87%901.18M | --996.69M | 182.58%1.43B | 14.18%505.19M | --442.45M |
-Accounts payable | --414.82M | 79.65%944.25M | ---- | -11.40%643.45M | -17.60%525.59M | --726.25M | 44.78%637.85M | 62.16%440.56M | --271.67M |
Contract liabilities | --18.7M | -92.47%4.66M | ---- | 18.34%26.06M | 103.60%61.89M | --22.02M | 324.88%30.4M | 182.64%7.15M | --2.53M |
Salaries payable | --70.34M | -23.91%68.76M | ---- | 45.38%64.71M | 64.01%90.36M | --44.51M | 97.77%55.1M | -26.72%27.86M | --38.02M |
Taxs payable | --76.25M | 22.37%68.96M | ---- | 18.16%90.73M | 49.21%56.35M | --76.79M | 40.02%37.76M | -3.25%26.97M | --27.88M |
Other payable (including interest and dividends) | --60.71M | 64.86%62.44M | ---- | 25.21%29.4M | 107.52%37.87M | --23.48M | 103.96%18.25M | -12.31%8.95M | --10.2M |
-Other payable | ---- | ---- | ---- | 25.21%29.4M | 107.52%37.87M | --23.48M | 103.96%18.25M | -12.31%8.95M | --10.2M |
Non current liabilities due within one year | --27.25M | -34.50%22.69M | ---- | 0.90%45.51M | -29.56%34.64M | --45.1M | 14.56%49.17M | 37.67%42.92M | --31.18M |
Other current liabilities | --2.66M | -66.14%270.77K | ---- | -37.99%2.14M | -83.51%799.74K | --3.46M | 820.35%4.85M | 223.86%526.99K | --162.72K |
Total current liabilities | --2.12B | 37.27%2.35B | ---- | -16.73%1.63B | -24.97%1.71B | --1.96B | 114.99%2.28B | 28.62%1.06B | --824.6M |
Current liabilities | |||||||||
Long term account payable | ---- | ---- | ---- | -82.21%699.21K | ---- | --3.93M | -79.82%15.89M | -27.37%78.74M | --108.42M |
Estimate liabilities | --57.22M | 38.28%53.38M | ---- | 60.71%45.9M | 50.10%38.6M | --28.56M | 110.83%25.72M | 81.21%12.2M | --6.73M |
Lease liabilities | --56.53M | 132.71%61.13M | ---- | 38.12%55.71M | 321.14%26.27M | --40.33M | -66.24%6.24M | --18.48M | ---- |
Total non current liabilities | --113.75M | 65.43%114.51M | ---- | 40.49%102.31M | 44.67%69.22M | --72.82M | -56.27%47.85M | -4.98%109.42M | --115.15M |
Total liabilities | --2.23B | 38.37%2.46B | --1.96B | -14.68%1.73B | -23.54%1.78B | --2.03B | 98.98%2.33B | 24.51%1.17B | --939.75M |
Shareholders equity | |||||||||
Paid-in capital | --422.4M | 0.00%380.16M | ---- | 0.00%380.16M | 0.00%380.16M | --380.16M | 0.00%380.16M | 5.60%380.16M | --360M |
Capital reserve funds | --1.83B | 1.11%852.79M | ---- | 1.34%849.15M | 1.24%843.43M | --837.95M | 1.30%833.1M | 57.62%822.42M | --521.77M |
Surplus reserve funds | --148.2M | 87.96%148.2M | ---- | 428.50%78.85M | 428.50%78.85M | --14.92M | 3,174.10%14.92M | 0.00%455.68K | --455.68K |
Retained profit | --1.48B | 92.32%1.34B | ---- | 165.55%1.07B | 762.64%694.2M | --404.68M | 171.34%80.47M | -6.22%-112.81M | ---106.2M |
Other composite income | --1.83M | -113.39%-487.89K | ---- | -79.25%1.87M | 37.48%3.64M | --9.02M | 255.04%2.65M | 374.70%746.65K | ---271.8K |
Shareholders equity without minority interests | --3.89B | 35.77%2.72B | --2.54B | 44.81%2.38B | 52.54%2B | --1.65B | 20.20%1.31B | 40.63%1.09B | --775.75M |
Minority interests | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.92%182.31K | --191.75K |
Total shareholder equity | --3.89B | 35.77%2.72B | --2.54B | 44.81%2.38B | 52.54%2B | --1.65B | 20.18%1.31B | 40.62%1.09B | --775.95M |
Total liabilityies and equity | --6.13B | 36.99%5.18B | --4.5B | 11.96%4.12B | 3.87%3.78B | --3.68B | 60.95%3.64B | 31.80%2.26B | --1.72B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | Unqualified opinion | -- | Unqualified opinion | Unqualified opinion | Unqualified opinion |
Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | KPMG Huazhen Certified Public Accountants (Special General Partnership) | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.